tamibarotene (Compound)

Synonyms:Tamibarotene, 94497-51-5, Am 80, 4-((5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbamoyl)benzoic acid, AM-80, retinobenzoic acid, Am80, Amnoid, Amnolake, Tamibaro, 4-[(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)carbamoyl]benzoic acid, TOS-80T, INNO-507, 4-[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbamoyl]benzoic acid, TM-411, NSC 608000, NSC-608000, Tamibarotene(Am-80), SY-1425, 4-((5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbamoyl)benzoic acid, CHEMBL25202, DTXSID5046853, C22H25NO3, CHEBI:32181, 08V52GZ3H9, OP-01, NSC608000, RR-110, Benzoic acid, 4-(((5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)amino)carbonyl)-, NCGC00181111-01, DTXCID3026853, 4-[[(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)amino]carbonyl]benzoic acid, SMR002530320, CAS-94497-51-5, Tamibarotene [INN], Amnoleuk, UNII-08V52GZ3H9, 2cbr, 4-(((5,6,7,8-TETRAHYDRO-5,5,8,8-TETRAMETHYL-2-NAPHTHALENYL)AMINO)CARBONYL)BENZOIC ACID, A80, Amnoid (TN), MFCD00866188, Tetrahydrofurfurylacrylate, and OP-01, Tamibarotene (JAN/INN), TAMIBAROTENE [MI], TAMIBAROTENE [JAN], Tamibarotene [USAN:INN], TAMIBAROTENE [USAN], SCHEMBL36207, TAMIBAROTENE [MART.], MLS003899239, MLS004774034, MLS006011150, TAMIBAROTENE [WHO-DD], GTPL2648, TOS-80, Tamibarotene, >=98% (HPLC), 4-[(1,1,4,4-tetramethyltetralin-6-yl)carbamoyl]benzoic acid, HMS3652H04, HMS3743C03, BCP07492, OMS-0728, WHO 7349, Tox21_112725, BDBM50061625, s4260, AKOS015902693, N-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)terephthalamic acid, Tox21_112725_1, AC-7049, CCG-268044, CS-0654, DB04942, NCGC00181111-02, 121GE003, AS-14083, HY-14652, NCI60_004716, AM20060757, FT-0601534, SW219913-1, Z-208, D01418, A844987, Q7681221, 4-(((5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)amino)carbonyl)benzoic acid, 4-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-ylcarbamoyl)benzoic acid, 4-[[(5,6,7,8-Tetrahydro-5,5,8,8-tet ramethyl-2-naphthalenyl)amino]carbonyl]benzoic acid, Terephthalic acid mono-5,5,8,8-tetramethyl- 5,6,7, 8-tetrahydro-2-naphthylamide, Terephthalic acid mono-5,8,8-tetramethyl- 5,6,7,8-tetrahydro-2-naphthylamide

Pubchem:PUBCHEM:108143

Id:94fc2430-62e0-5998-b8b5-49903cd3a351

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View tamibarotene's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for tamibarotene.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with tamibarotene.

Results found

Linked to

	Label	Description
	BRD-K36627727-001-05-4 Substance (Entity type)	A Substance
	DCSTRUCT ID 03580 Collection (Entity type)	DrugPage Collection: (DrugCentralID:03580; PubChem_CID:108143, FILE=drugcentral_drug_03580.json)
	tamibarotene (8d34a1aa-5523-402d-a4a6-501759d60879) Collection (Entity type)	Metadatata for tamibarotene
	tamibarotene positively regulates TCN1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	tamibarotene positively regulates ALDH1A3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	tamibarotene in similarity relationship with tretinoin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	tamibarotene positively regulates HERC5 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	tamibarotene in similarity relationship with AC-55649 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	SID11114260 in similarity relationship with tamibarotene Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	13-cis retinoic acid in similarity relationship with tamibarotene Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS